Nuveen Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.29M | Sell |
423,189
-32,124
| -7% | -$97.7K | ﹤0.01% | 2593 |
|
|
2024
Q3 | $2.36M | Sell |
455,313
-600,749
| -57% | -$3.12M | ﹤0.01% | 2334 |
|
|
2024
Q2 | $2.71M | Buy |
1,056,062
+704,020
| +200% | +$1.81M | ﹤0.01% | 2231 |
|
|
2024
Q1 | $1.73M | Sell |
352,042
-181,154
| -34% | -$891K | ﹤0.01% | 2461 |
|
|
2023
Q4 | $4.69M | Sell |
533,196
-70,301
| -12% | -$618K | ﹤0.01% | 2019 |
|
|
2023
Q3 | $6.92M | Buy |
603,497
+201,103
| +50% | +$2.31M | ﹤0.01% | 1697 |
|
|
2023
Q2 | $10.2M | Buy |
402,394
+112
| +0% | +$2.84K | ﹤0.01% | 1495 |
|
|
2023
Q1 | $13M | Sell |
402,282
-98,565
| -20% | -$3.17M | ﹤0.01% | 1318 |
|
|
2022
Q4 | $9.25M | Sell |
500,847
-118,317
| -19% | -$2.18M | ﹤0.01% | 1546 |
|
|
2022
Q3 | $16.7M | Buy |
619,164
+260,044
| +72% | +$7.02M | 0.01% | 1136 |
|
|
2022
Q2 | $4.96M | Sell |
359,120
-11,701
| -3% | -$162K | ﹤0.01% | 1944 |
|
|
2022
Q1 | $7.07M | Sell |
370,821
-2,911
| -0.8% | -$55.5K | ﹤0.01% | 1861 |
|
|
2021
Q4 | $6.1M | Sell |
373,732
-10,932
| -3% | -$178K | ﹤0.01% | 2006 |
|
|
2021
Q3 | $10.7M | Sell |
384,664
-176,430
| -31% | -$4.92M | ﹤0.01% | 1728 |
|
|
2021
Q2 | $16.6M | Buy |
561,094
+104,771
| +23% | +$3.11M | 0.01% | 1511 |
|
|
2021
Q1 | $12.8M | Sell |
456,323
-19,826
| -4% | -$554K | ﹤0.01% | 1642 |
|
|
2020
Q4 | $13.5M | Buy |
476,149
+50,128
| +12% | +$1.42M | ﹤0.01% | 1508 |
|
|
2020
Q3 | $10.7M | Buy |
426,021
+25,165
| +6% | +$633K | ﹤0.01% | 1479 |
|
|
2020
Q2 | $9.79M | Buy |
400,856
+49,606
| +14% | +$1.21M | ﹤0.01% | 1499 |
|
|
2020
Q1 | $5.2M | Buy |
351,250
+24,534
| +8% | +$363K | ﹤0.01% | 1695 |
|
|
2019
Q4 | $5.3M | Buy |
326,716
+19,344
| +6% | +$314K | ﹤0.01% | 1963 |
|
|
2019
Q3 | $4M | Buy |
307,372
+104,035
| +51% | +$1.35M | ﹤0.01% | 2074 |
|
|
2019
Q2 | $2.64M | Buy |
+203,337
| New | +$2.64M | ﹤0.01% | 2298 |
|